SCHEMBL23093006

SCHEMBL23093006

Cc1cc(CCCN=[N+]=[N-])ccc1NC(=O)OC(C)(C)C

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ SMN1; SMN2 Q16637 3/20 0.41
▸ TP53 P04637 2/20 0.39
▸ TSHR P16473 2/20 0.39
▸ ADRB2 P07550 2/20 0.39
▸ MEN1 O00255 1/20 0.38
▸ KMT2A Q03164 1/20 0.38
▸ MAPT P10636 1/20 0.38
▸ POLB P06746 1/20 0.38
▸ ATM Q13315 1/20 0.38
▸ KCNQ4 P56696 3/20 0.37
▸ KCNQ5 Q9NR82 3/20 0.37
▸ CISD2 Q8N5K1 1/20 0.37
▸ L3MBTL1 Q9Y468 2/20 0.37
▸ NR1H4 Q96RI1 1/20 0.37
▸ CYP1A2 P05177 1/20 0.36
▸ CYP2C9 P11712 1/20 0.36
▸ CYP2C19 P33261 1/20 0.36
▸ ALDH1A1 P00352 2/20 0.36
▸ HPGD P15428 2/20 0.36
▸ NPSR1 Q6W5P4 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23093086 0.83 SMN1; SMN2 (0.43) SMN1; SMN2TP53TSHRMEN1KMT2A
SCHEMBL23093142 0.83 SMN1; SMN2 (0.47) SMN1; SMN2TP53TSHRMEN1KMT2A
SCHEMBL23092969 0.82 SMN1; SMN2 (0.46) SMN1; SMN2TP53TSHRMEN1KMT2A
SCHEMBL23092995 0.82 SMN1; SMN2 (0.43) SMN1; SMN2TP53TSHRMEN1KMT2A
SCHEMBL5162892 0.78 SMN1; SMN2 (0.48) SMN1; SMN2MEN1KMT2AMAPTPOLB
SCHEMBL23093001 0.77 KCNQ4 (0.39) SMN1; SMN2TP53TSHRMEN1KMT2A
SCHEMBL6676620 0.76 SMN1; SMN2 (0.47) SMN1; SMN2MEN1KMT2AMAPTPOLB
SCHEMBL8297312 0.76 SMN1; SMN2 (0.63) SMN1; SMN2TP53MEN1KMT2AMAPT
SCHEMBL24723482 0.74 CYP17A1 (0.51) —
SCHEMBL14088041 0.74 AAK1 (0.41) SMN1; SMN2CYP1A2CYP2C9CYP2C19HPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2021050547-A1 MITOCHONDRIAL COMPLEX I INHIBITORS AND METHODS OF USE Sanford Burnham Prebys Medical Discovery Institute (US) 2021-03-18 — — WO disclosed
Send feedback